Two Sigma Investments’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$329K Sell
2024
Q3
$564K Buy
2024
Q2
$403K Buy
2022
Q3
Sell
2022
Q2
$145K Sell
2022
Q1
$459K Sell
2021
Q4
$590K Buy
2021
Q3
$1.02M Buy
2021
Q2
Sell
2021
Q1
$430K Buy